These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9600034)

  • 41. Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records.
    Menzin J; Hoesche J; Friedman M; Nichols C; Bergman GE; Crowther M; Garcia D; Jones C
    J Thromb Haemost; 2012 Apr; 10(4):596-605. PubMed ID: 22257107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. At peace with warfarin. 8 tips for staying on the safe side of this important "blood thinner".
    Harv Heart Lett; 2003 Jul; 13(11):4-5. PubMed ID: 12888477
    [No Abstract]   [Full Text] [Related]  

  • 43. Possible limitations of using the HAS-BLED bleeding score in real life settings.
    Gulec S
    Thromb Res; 2014 Jun; 133(6):959-60. PubMed ID: 24525313
    [No Abstract]   [Full Text] [Related]  

  • 44. [Noscapine and warfarin--a potentially dangerous interaction].
    Myhr K
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):540. PubMed ID: 19282895
    [No Abstract]   [Full Text] [Related]  

  • 45. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predisposing preventable factors in patients with bleeding due to warfarin usage: Evaluation of 114 patients.
    Beyan E; Beyan C; Vaizoğlu SA
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):684-7. PubMed ID: 19520686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Concomitant use of warfarin, analgesics and anti-inflammatory agents].
    Håkonsen GD; Pettersen MH; Skurtveit S; Giverhaug T
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1217-20. PubMed ID: 19521444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prospective assessment of bleeding and international normalized ratio in warfarin-anticoagulated patients having cutaneous surgery.
    Syed S; Adams BB; Liao W; Pipitone M; Gloster H
    J Am Acad Dermatol; 2004 Dec; 51(6):955-7. PubMed ID: 15583588
    [No Abstract]   [Full Text] [Related]  

  • 49. A case of sulphasalazine potentiating the hypoprothombinemic effect of warfarin resulting in bleeding.
    Hall S; Rindone JP
    J Clin Pharm Ther; 2011 Apr; 36(2):246-8. PubMed ID: 21366655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
    Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle.
    Kucher N; Connolly S; Beckman JA; Cheng LH; Tsilimingras KV; Fanikos J; Goldhaber SZ
    Arch Intern Med; 2004 Oct; 164(19):2176-9. PubMed ID: 15505133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Warfarin-bosentan interaction. Risk of big INR changes].
    Holm L; Jansson A; Noher H
    Lakartidningen; 2007 Aug 8-21; 104(32-33):2248. PubMed ID: 17822204
    [No Abstract]   [Full Text] [Related]  

  • 53. [Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
    Syrjälä M
    Duodecim; 1998; 114(6):573-5. PubMed ID: 11466922
    [No Abstract]   [Full Text] [Related]  

  • 54. Long-term anticoagulation prophylaxis following acute thromboembolism.
    Hyers TM
    Dis Mon; 2005; 51(2-3):158-65. PubMed ID: 15900268
    [No Abstract]   [Full Text] [Related]  

  • 55. Interaction of dicloxacillin with warfarin.
    Lacey CS
    Ann Pharmacother; 2004 May; 38(5):898. PubMed ID: 15054148
    [No Abstract]   [Full Text] [Related]  

  • 56. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation.
    Howard PA; Ellerbeck EF; Engelman KK; Patterson KL
    Pharmacoepidemiol Drug Saf; 2002; 11(7):569-76. PubMed ID: 12462133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fatal bleeding under warfarin plus cranberry juice. Is it due to salicylic acid?].
    Isele H
    MMW Fortschr Med; 2004 Mar; 146(11):13. PubMed ID: 15152759
    [No Abstract]   [Full Text] [Related]  

  • 59. Dependency rather than old age increases the risk of warfarin-related bleeding.
    Goudie BM; Donnan PT; Fairfield G; Al-Agilly SS; Cachia PG
    Br J Gen Pract; 2004 Sep; 54(506):690-2. PubMed ID: 15353056
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Warfarin users, beware of antibiotics. Interactions may increase the risk of internal bleeding.
    Harv Heart Lett; 2012 Jun; 22(10):3. PubMed ID: 22764397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.